Fibrates for primary biliary cholangitis: What’s all the hype?

Research output: Contribution to journalArticlepeer-review

1 Scopus citations

Abstract

Ursodeoxycholic acid is the first-line therapy for primary biliary cholangitis. However, a subset of patients fail to show biochemical response. For these patients, adjuvant therapies are warranted. Obeticholic acid was conditionally approved as a second-line drug. Evidence is building up in favor of fibrates, which are available for off-label use.

Original languageEnglish (US)
Pages (from-to)704-706
Number of pages3
JournalAnnals of Hepatology
Volume16
Issue number5
DOIs
StatePublished - Sep 1 2017

Keywords

  • Fibrates
  • Obeticholic acid
  • Primary biliary cholangitis
  • Treatment

ASJC Scopus subject areas

  • Hepatology

Fingerprint

Dive into the research topics of 'Fibrates for primary biliary cholangitis: What’s all the hype?'. Together they form a unique fingerprint.

Cite this